For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
News Release
McConnell Plan to Raise Nicotine Access to Age 21 Could Backfire
Citing health concerns about youth vaping, Senate Majority Leader Mitch McConnell (R-Kentucky) announced legislation to raise the nationwide minimum age to buy tobacco products from…
Medium
The FDA’s Runaway Trolley Problem
If you’ve ever participated in a thought experiment, you know how fun that can be. The most famous is the Trolley Problem, entertainingly portrayed by…
American Chemistry
IRIS: Bad Science, Real World Consequences
American Chemistry cited CEI’s publication by Senior Fellow Angela Logomasini on the IRIS. In February 2019 the Competitive Enterprise Institute (CEI) provided some important…
Comment
CEI Comments to FDA on Modifications to Compliance Policy for Certain Deemed Tobacco Products
Dear Dr. Gottlieb: The Competitive Enterprise Institute (CEI) welcomes the opportunity to offer the following comments on the Food and Drug Administration’s (FDA) proposed modifications…
Real Clear Policy
Federal Pot Prohibition Nears its End
America has made up its mind on marijuana. Most Americans think it should be legal, and all but two states have decriminalized or legalized the drug in…
News Release
CEI Report Calls for Elimination of EPA’s Flawed Integrated Risk Information System
A new report released today by the Competitive Enterprise Institute (CEI) shows EPA’s Integrated Risk Information System (IRIS) has significant problems with methodology, relies on…